- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 245/04 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 245/04
Total number of patents in this class: 62
10-year publication summary
|
9
|
7
|
1
|
1
|
3
|
3
|
4
|
2
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4099 |
5 |
| RQX Pharmaceuticals, Inc. | 13 |
5 |
| Revolution Medicines, Inc. | 329 |
4 |
| The Regents of the University of Michigan | 4979 |
3 |
| Arizona Board of Regents on behalf of Arizona State University | 2930 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| Samsung Display Co., Ltd. | 38570 |
2 |
| Industry-Academic Cooperation Foundation Gyeongsang National University | 631 |
2 |
| Vironova Thionation AB | 5 |
2 |
| Universite de Caen Normandie | 127 |
2 |
| Insilico Medicine IP Limited | 124 |
2 |
| F. Hoffmann-La Roche AG | 7836 |
1 |
| The Regents of the University of California | 20720 |
1 |
| Merck Patent GmbH | 5725 |
1 |
| FUJIFILM Corporation | 30512 |
1 |
| Samsung SDI Co., Ltd. | 10556 |
1 |
| The Board of Trustees of the University of Illinois | 2750 |
1 |
| Arrowhead Pharmaceuticals, Inc. | 347 |
1 |
| Board of Trustees of the University of Arkansas | 825 |
1 |
| Cidara Therapeutics, Inc. | 72 |
1 |
| Other owners | 21 |